1. NSDUH. Results from the 2004 National Survey on Drug Use and Health: national findings. Rockville: Substance Abuse and Mental Health Services Administration, 2005:.

2. EMCDDA. The state of the drugs problem in Europe: annual report 2005. European Monitoring Centre for Drugs and Drug Addiction, 2005:.

3. WHO. Cannabis: a health perspective and research agenda. World Health Organization, 1997:.

4. Webb E, Ashton CH, Kelly P, Kamali F. Alcohol and drug use in UK university students. Lancet 1996; 348: 922-925. Abstract | Full Text | Full-Text PDF (40 KB) | MEDLINE | CrossRef

5. Fergusson DM, Horwood LJ. Cannabis use and dependence in a New Zealand birth cohort. N Z Med J 2000; 113: 156-158. MEDLINE

6. Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003; 28: 1760-1769. CrossRef

7. D'Souza DC, Perry E, MacDougall L, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004; 29: 1558-1572. CrossRef

8. Isbell H, Gorodetzsky CW, Jasinski D, Claussen U, von Spulak F, Korte F. Effects of (--)delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia 1967; 11: 184-188. MEDLINE | CrossRef

9. Melges FT, Tinklenberg JR, Deardorff CM, Davies NH, Anderson RE, Owen CA. Temporal disorganization and delusional-like ideation. Processes induced by hashish and alcohol. Arch Gen Psychiatry 1974; 30: 855-861.

10. Renault PF, Schuster CR, Freedman DX, Sikic B, de Mello DN. Repeat administration of marihuana smoke to humans. Arch Gen Psychiatry 1974; 31: 95-102.

11. Keeler MH. Marihuana induced hallucinations. Dis Nerv Syst 1968; 29: 314-315. MEDLINE

12. Tart CT. Marijuana intoxication common experiences. Nature 1970; 226: 701-704. MEDLINE | CrossRef

13. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996; 42: 201-207. MEDLINE | CrossRef

14. RCP. Cannabis and cannabis-based medicines. London: Royal College of Physicians, 2005:.

15. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110-117. MEDLINE | CrossRef

16. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493-1504. MEDLINE | CrossRef

17. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608-612. MEDLINE | CrossRef

18. Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579-1588. Abstract | Full Text | Full-Text PDF (119 KB) | CrossRef

19. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005; 19: 187-194. MEDLINE | CrossRef

20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. MEDLINE | CrossRef

21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558. MEDLINE | CrossRef

22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.

23. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. MEDLINE | CrossRef

24. Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis 1990; 178: 473-480. MEDLINE

25. Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11.

26. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002; 156: 319-327. MEDLINE | CrossRef

27. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British national psychiatric morbidity survey. Br J Psychiatry 2006; 188: 519-526. MEDLINE | CrossRef

28. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483-1486. MEDLINE

29. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1199.

30. Zammit S. An investigation into the use of cannabis and tobacco as risk factors for schizophrenia. PhD thesis. Cardiff University, 2004:.

31. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-1213.

32. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005; 57: 1117-1127. Abstract | Full Text | Full-Text PDF (224 KB) | MEDLINE | CrossRef

33. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15-21. MEDLINE | CrossRef

34. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100: 354-366. MEDLINE | CrossRef

35. Fergusson DM, Lynskey MT, Horwood LJ. The short-term consequences of early onset cannabis use. J Abnorm Child Psychol 1996; 24: 499-512. MEDLINE | CrossRef

36. Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997; 92: 279-296. MEDLINE | CrossRef

37. Fergusson DM, Horwood LJ, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002; 97: 1123-1135. MEDLINE | CrossRef

38. McGee R, Williams S, Poulton R, Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 2000; 95: 491-503. MEDLINE | CrossRef

39. Block JH, Gjerde PF. Personality antecedents of depressive tendencies in 18-year-olds: a prospective study. J Pers Soc Psychol 1991; 60: 726-738. MEDLINE | CrossRef

40. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158: 2033-2037. CrossRef

41. Crum RM, Anthony JC. Cocaine use and other suspected risk factors for obsessive–compulsive disorder: a prospective study with data from the epidemiologic catchment area surveys. Drug Alcohol Depend 1993; 31: 281-295. MEDLINE | CrossRef

42. Brook JS, Cohen P, Brook DW. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 1998; 37: 322-330. MEDLINE

43. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 2002; 59: 1039-1044. CrossRef

44. Beard JR, Dietrich UC, Brooks LO, Brooks RT, Heathcote K, Kelly B. Incidence and outcomes of mental disorders in a regional population: the Northern Rivers Mental Health Study. Aust N Z J Psychiatry 2006; 40: 674-682. MEDLINE | CrossRef

45. Brook JS, Rosen Z, Brook DW. The effect of early marijuana use on later anxiety and depressive symptoms. NYS Psychologist January 2001; 35-40(New York).

46. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195-1198.

47. Borowsky IW, Ireland M, Resnick MD. Adolescent suicide attempts: risks and protectors. Pediatrics 2001; 107: 485-493.

48. Wade TJ, Pevalin DJ. Adolescent delinquency and health. Can J Criminol Crim Just 2005; 47: 619-654.

49. Wilcox HC. The development of suicide ideation and attempt: an epidemiologic study of first graders followed into young adulthood. PhD thesis. John Hopkins University, 2003:.

50. Juon HS, Ensminger ME. Childhood, adolescent, and young adult predictors of suicidal behaviors: a prospective study of African Americans. J Child Psychol Psychiatry 1997; 38: 553-563. MEDLINE | CrossRef

51. Newcomb MD, Scheier LM, Bentler PM. Effects of adolescent drug use on adult mental health: a prospective study of a community sample. Exp Clin Psychopharmacol 1993; 1: 215-241. CrossRef

52. Newcomb MD, Vargas-Carmona J, Galaif ER. Drug problems and psychological distress among a community sample of adults: predictors, consequences, or confound?. J Commun Psychol 1999; 27: 405-429.

53. Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Dev Psychopathol 2004; 16: 1007-1027. MEDLINE | CrossRef

54. Paton S, Kessler R, Kandel D. Depressive mood and adolescent illicit drug use: a longitudinal analysis. J Genet Psychol 1977; 131: 267-289. MEDLINE

55. Kandel DB, Davies M. Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry 1986; 43: 255-262.

56. Henquet C, Rosa A, Krabbendam L, et al. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006; 31: 2748-2757. CrossRef

57. Smith NT. A review of the published literature into cannabis withdrawal symptoms in human users. Addiction 2002; 97: 621-632. MEDLINE | CrossRef

58. Allott K, Chanen A, Yuen HP. Attrition bias in longitudinal research involving adolescent psychiatric outpatients. J Nerv Ment Dis 2006; 194: 958-961. MEDLINE | CrossRef

59. Fischer EH, Dornelas EA, Goethe JW. Characteristics of people lost to attrition in psychiatric follow-up studies. J Nerv Ment Dis 2001; 189: 49-55. MEDLINE | CrossRef

60. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003; 71: 37-48. MEDLINE | CrossRef

61. Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB. Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007; 102: 597-606. MEDLINE | CrossRef

62. Smith GD, Ebrahim S. Data dredging, bias, or confounding. BMJ 2002; 325: 1437-1438.

63. Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006; 333: 1114-1117.

64. Chen J, Marmur R, Pulles A, Paredes W, Gardner EL. Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient. Brain Res 1993; 621: 65-70. MEDLINE | CrossRef

65. Pistis M, Ferraro L, Pira L, et al. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res 2002; 948: 155-158. MEDLINE | CrossRef

66. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 2005; 40: 2-14. MEDLINE | CrossRef

67. Heresco-Levy U. Chapter XVII-3: Amino acid transmitter systems In:  D'haenen HAH,  den Boer JA,  Willner P, eds. Biological psychiatry. Chichester: Wiley,  2002: 587-600.

68. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998; 316: 140-144.

69. O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol 2006; 20: 611-621. MEDLINE | CrossRef